Synchronous colorectal liver metastases:therapeutic considerations  

作　　者：Michael R.Driedger Sean P.Cleary David M.Nagorney 

机构地区：[1]Division of Hepatobiliary and Pancreatic Surgery,Atrium Health,Charlotte,NC,USA [2]Division of Hepatobiliary and Pancreatic Surgery,Mayo Clinic,Rochester,MN,USA

出　　处：《Hepatobiliary Surgery and Nutrition》2021年第5期711-713,共3页肝胆外科与营养（英文）

摘　　要：More than 50%of patients will develop colorectal cancer(CRC)liver metastases(CRCLM)during the course of their disease,while 15-25%of patients will have metastatic disease present at the time of initial diagnosis.Resection of CRCLM is possible in approximately one-in-four patients and 5-year overall survival(OS)rates have improved to nearly 60%in selected patients who undergo resection.

关 键 词：COLORECTAL METASTASES PATIENTS 

分 类 号：R73[医药卫生—肿瘤]